Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Cancer Research

• Publication date

  2010-01-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-09-2730PMID 20103663PMCID PMC2842003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo imaging, tracking, and targeting of cancer stem cells.

  2009influential reference
• Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

  2009cited by this paper
• Genomic and Expression Profiling of Glioblastoma Stem Cell–Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival

  2009cited by this paper
• Proteomic and immunologic analyses of brain tumor exosomes

  2009cited by this paper
• Application of a Flow Cytometric Cytotoxicity Assay for Monitoring Cancer Vaccine Trials

  2009cited by this paper
• The Prolyl Isomerase Pin1 Regulates the NF-κB Signaling Pathway and Interleukin-8 Expression in Glioblastoma

  2009cited by this paper
• Soluble mediators from human neural stem cells play a critical role in suppression of T‐cell activation and proliferation

  2009cited by this paper
• Antigen‐Specific T‐Cell Response from Dendritic Cell Vaccination Using Cancer Stem‐Like Cell‐Associated Antigens

  2009cited by this paper
• HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank

  2009cited by this paper
• Relationship between CD107a expression and cytotoxic activity.

  2009cited by this paper
• Preferential In Situ CD4+CD56+ T Cell Activation and Expansion within Human Glioblastoma

  2008cited by this paper
• B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells

  2008cited by this paper
• Issues of Diagnostic Review in Brain Tumor Studies: From the Brain Tumor Epidemiology Consortium

  2008influential reference
• Cell- and peptide-based immunotherapeutic approaches for glioma.

  2008influential reference
• Loss of Protein Inhibitors of Activated STAT-3 Expression in Glioblastoma Multiforme Tumors: Implications for STAT-3 Activation and Gene Expression

  2008cited by this paper
• Induction of Both CD8+ and CD4+ T-Cell–Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1

  2008cited by this paper
• Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

  2007influential reference
• Identification and expansion of human colon-cancer-initiating cells

  2007cited by this paper
• Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

  2007cited by this paper
• Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma

  2007cited by this paper
• NKG2D-Mediated Antitumor Activity by Tumor-Infiltrating Lymphocytes and Antigen-Specific T-Cell Clones Isolated from Melanoma Patients

  2007cited by this paper
• Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy

  2007cited by this paper
• Cancer stem cells and oncology therapeutics

  2007cited by this paper
• Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

  2007cited by this paper
• Loss of expression of antigen‐presenting molecules in human pancreatic cancer and pancreatic cancer cell lines

  2007cited by this paper
• Antigenic Profiling of Glioma Cells to Generate Allogeneic Vaccines or Dendritic Cell–Based Therapeutics

  2007influential reference
• Brain tumour stem cells

  2006cited by this paper
• Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy

  2006influential reference
• Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

  2006influential reference
• Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.

  2006cited by this paper
• Roots and stems: stem cells in cancer

  2006cited by this paper
• Application of the Granzyme B ELISPOT Assay for Monitoring Cancer Vaccine Trials

  2006cited by this paper
• Expression of MHC I and NK ligands on human CD133 + glioma cells: possible targets of immunotherapy

  2006cited by this paper
• RNA amplification for successful gene profiling analysis

  2005cited by this paper
• Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters

  2005cited by this paper
• Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.

  2005cited by this paper
• EXPRESSION OF UBIQUITIN-SPECIFIC PROTEASE 14 IN HUMAN PANCREATIC CANCER CELL LINES AND CANCER TISSUES

  2005cited by this paper
• Glioblastoma Patients Exhibit Circulating Tumor-Specific CD8+ T Cells

  2005cited by this paper
• Neural stem cells and neurospheres—re-evaluating the relationship

  2005cited by this paper
• Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment

  2005cited by this paper
• Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma

  2004influential reference
• Primary brain tumours in adults.

  2003influential reference
• Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes.

  2003influential reference
• Identification of a cancer stem cell in human brain tumors.

  2003cited by this paper
• Primary brain tumours in adults.

  2003cited by this paper
• DAVID: Database for Annotation, Visualization, and Integrated Discovery

  2003cited by this paper
• Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining.

  2003cited by this paper
• DAVID: Database for Annotation, Visualization, and Integrated Discovery

  2003cited by this paper
• Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain.

  2002cited by this paper
• Stat proteins and oncogenesis.

  2002cited by this paper
• Identification of a Novel HLA-A*0201-restricted, Cytotoxic T Lymphocyte Epitope in a Human Glioma-associated Antigen, Interleukin 13 Receptor α2 Chain

  2002cited by this paper
• Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients.

  2001cited by this paper
• Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.

  2001influential reference
• Glioma immunology and immunotherapy.

  2000cited by this paper
• High-fidelity mRNA amplification for gene profiling

  2000cited by this paper
• Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines.

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Oligotyping of HLA-A2, -A3, and -B44 subtypes. Detection of subtype incompatibilities between patients and their serologically matched unrelated bone marrow donors.

  1994cited by this paper

• Prophylactic and therapeutic CSC-based vaccination reduced tumor growth, metastasis and enhanced survival in mouse model of breast cancer.

  2026cites this paper
• Mapping kinase-dependent tumor immune adaptation with multiplexed single-cell CRISPR screens

  2026cites this paper
• Targeting cancer stem cells as the most aggressive and tumor-initiating cells

  2026cites this paper
• Ultrasmall zwitterion-micelles coupled with anti-checkpoint antibody for overcoming glioma barriers to eliminate stem cells and amplify immunotherapy.

  2026cites this paper
• Advancements in cancer stem cell therapy: The effective integration of traditional Chinese medicine and nanotechnology.

  2026cites this paper
• Cytomegalovirus-induced oncomodulation drives immune escape in glioblastoma

  2025cites this paper
• The immunomodulatory role of tumor-initiating cells in digestive system tumors: from mechanisms to therapy

  2025cites this paper
• Crosstalk between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and immunotherapy

  2025cites this paper
• Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance

  2025cites this paper
• A Novel Class of Multi‐substituted Diaryl Scaffold Derivatives Inhibit Glioblastoma Progression by Targeting CD155

  2025cites this paper
• Immunotherapy for High-Grade Gliomas

  2025cites this paper
• Breaking Immunosuppression to Enhance Cancer Stem Cell-Targeted Immunotherapy

  2025cites this paper
• Advances in stem cell-based therapeutic transfers for glioblastoma treatment

  2025cites this paper
• ACYP2 Induces Temozolomide Resistance in Glioblastoma by Promoting PARP1-Mediated DNA Damage Repair

  2025cites this paper
• Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma

  2025cites this paper
• CCL20/CXCL5 Drives Crosstalk Between Anaplastic Thyroid Cancer Stem Cells and Tumor‐Associated Macrophages to Promote Tumor Progression

  2025cites this paper
• The integrative genomic and functional immunological analyses of colorectal cancer initiating cells to modulate stemness properties and the susceptibility to immune responses

  2025cites this paper
• Cancer stem cells and niches: challenges in immunotherapy resistance

  2025cites this paper
• Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer

  2025cites this paper
• Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities

  2025cites this paper
• Cancer Stem Cells Decide the Fate of Cancer Immunotherapy by Remodeling Tumor Microenvironment

  2025cites this paper
• Co‐assembled Manganese‐CpG Nanoliposomes for Enhanced Immunotherapy against Colon Cancer Stem Cells

  2025cites this paper
• The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy

  2025cites this paper
• Co-Colorectal cancer stem cells employ the FADS1/DDA axis to evade NK cell-mediated immunosuppression after co-cultured with NK cells under hypoxia

  2024cites this paper
• Stemness subtypes in lower-grade glioma with prognostic biomarkers, tumor microenvironment, and treatment response

  2024cites this paper
• Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments

  2024cites this paper
• Crosstalk between cancer cell plasticity and immune microenvironment in cholangiocarcinoma

  2024cites this paper
• A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma.

  2024cites this paper
• Targeted immunotherapy to cancer stem cells: a novel strategy of anticancer immunotherapy.

  2024cites this paper
• Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression

  2024cites this paper
• Discovery of Novel N-(Anthracen-9-ylmethyl) Benzamide Derivatives as ZNF207 Inhibitors Promising in Treating Glioma.

  2024cites this paper
• Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells

  2024influential citation
• Integration of single-cell sequencing and bulk transcriptome data develops prognostic markers based on PCLAF+ stem-like tumor cells using artificial neural network in gastric cancer

  2024cites this paper
• Long-term Hypoxia Inhibits Sphere Formation on PC-3 and MDA-MB-231 Cell Line Models

  2024cites this paper
• Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives

  2024cites this paper
• Epigenetic control of immunoevasion in cancer stem cells.

  2024cites this paper
• Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth

  2024cites this paper
• Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment

  2023cites this paper
• The tumour ecology of quiescence: niches across scales of complexity.

  2023cites this paper
• Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies

  2023cites this paper
• The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update.

  2023cites this paper
• IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy.

  2023cites this paper
• LncRNA and its role in gastric cancer immunotherapy

  2023cites this paper
• Exploring Novel Therapeutic Opportunities for Glioblastoma Using Patient-Derived Cell Cultures

  2023cites this paper
• Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota

  2023cites this paper
• Unravelling the Therapeutic Potential of Antibiotics in Hypoxia in a Breast Cancer MCF-7 Cell Line Model

  2023cites this paper
• The Role of Cellular Immunity and Adaptive Immunity in Pathophysiology of Brain and Spinal Cord Tumors.

  2023cites this paper
• Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy

  2023cites this paper
• Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23

  2023cites this paper
• Immunobiology of cancer stem cells and their immunoevasion mechanisms

  2023cites this paper
• Cancer stem cells in brain tumors: From origin to clinical implications

  2023cites this paper
• Cancer Stem Cells in Tumours of the Central Nervous System in Children: A Comprehensive Review

  2023cites this paper
• Immune evasion and therapeutic opportunities based on natural killer cells.

  2023cites this paper
• Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8 + T cells

  2023cites this paper
• The role of tumor microenvironment on cancer stem cell fate in solid tumors

  2023cites this paper
• Rough neighborhood: Intricacies of cancer stem cells and infiltrating immune cell interaction in tumor microenvironment and potential in therapeutic targeting.

  2023cites this paper
• Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis

  2022cites this paper
• Current Immunotherapeutic Approaches for Malignant Gliomas

  2022cites this paper
• Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results

  2022cites this paper
• Regulatory networks driving expression of genes critical for glioblastoma are controlled by the transcription factor c-Jun and the pre-existing epigenetic modifications

  2022cites this paper
• Specific Targeting of Cancer Stem Cells by Immunotherapy: A Possible Stratagem to Restrain Cancer Recurrence and Metastasis.

  2022cites this paper
• MicroRNA and mRNA Expression Changes in Glioblastoma Cells Cultivated under Conditions of Neurosphere Formation

  2022cites this paper
• Updates of Role of Stem Cells in Cancer Therapy

  2022cites this paper
• Prolonged survival in patients with local chronic infection after high-grade glioma treatment: Two case reports

  2022cites this paper
• Non-coding RNAs and glioma: Focus on cancer stem cells

  2022cites this paper
• Cancer resistance to immunotherapy: What is the role of cancer stem cells?

  2022cites this paper
• Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer

  2022cites this paper
• The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity

  2022cites this paper
• Cancer Stem Cells: The Greatest Menace in Conquering Cancer Management

  2022cites this paper
• Gamma Irradiation Triggers Immune Escape in Glioma-Propagating Cells

  2022cites this paper
• Targeting Cancer Stem Cells: Therapeutic and diagnostic strategies by the virtue of nanoparticles.

  2022cites this paper
• Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity

  2022cites this paper
• KRAB-ZFPs and cancer stem cells identity

  2022cites this paper
• Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing

  2022cites this paper
• LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer

  2022cites this paper
• Checkpoints and Immunity in Cancers: Role of GNG12.

  2022cites this paper
• Glioblastoma microenvironment: The stromal interactions.

  2022cites this paper
• Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma

  2022cites this paper
• Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence

  2022cites this paper
• High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach

  2022cites this paper
• Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies

  2022cites this paper
• Utility of the Cerebral Organoid Glioma ‘GLICO’ Model for Screening Applications

  2022cites this paper
• Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models

  2021cites this paper
• The Role of the Renin–Angiotensin System in the Cancer Stem Cell Niche

  2021cites this paper
• Cancer stem cell–immune cell crosstalk in tumour progression

  2021cites this paper
• Long non-coding RNAs in cancer stem cells

  2021cites this paper
• MicroRNA Expression Profile Distinguishes Glioblastoma Stem Cells from Differentiated Tumor Cells

  2021influential citation
• Hot or Cold: Bioengineering Immune Contextures into In Vitro Patient-Derived Tumor Models.

  2021cites this paper
• Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance

  2021cites this paper
• The role of peptidases and their endogenous inhibitors in the regulation of NK cell cytotoxicity

  2021cites this paper
• Modulation of Immune Components on Stem Cell and Dormancy in Cancer

  2021cites this paper
• Analysis of Several Pathways for Efficient Killing of Prostate Cancer Stem Cells: A Central Role of NF-κB RELA

  2021cites this paper
• Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy.

  2021cites this paper
• Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients

  2021cites this paper
• Molecular Mechanisms of Drug Resistance in Glioblastoma

  2021cites this paper
• The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure

  2021cites this paper
• Immune evasion by cancer stem cells

  2021influential citation
• Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective

  2021cites this paper
• GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy

  2021cites this paper
• Targeting Glioma Stem Cells.

  2021cites this paper